Cognitive dysfunction among newly diagnosed older patients with hematological malignancy: frequency, clinical indicators and predictors

Abstract

The prevalence rate of cognitive dysfunction was non-negligible among older patients with hematologic malignancy before and immediately after initial chemotherapy. Attention to the clinical indicators and predictors found in this study may provide facilitate the identification of cognitive dysfunction in patients with cancer.